Theranostic cancer treatment using lentinan-coated selenium nanoparticles and label-free cest mri

HIGHLIGHTS

  • who: Guanfu Liu and collaborators from the Department of Radiology, The First Affiliated Hospital of Jinan University, Guangzhou, China have published the paper: Theranostic Cancer Treatment Using Lentinan-Coated Selenium Nanoparticles and Label-Free CEST MRI, in the Journal: Pharmaceutics 2023, 15, 120. of /2023/
  • what: Taken together the study demonstrates the first label-free SeNP-based theranostic system in which LNT was used for both functional surface coating and CEST MRI signal generating. The authors aim to develop a label-free approach for MRI detection of LNT-SeNPs and use it to monitor the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?